Gain Therapeutics Inc
NASDAQ:GANX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gain Therapeutics Inc
NASDAQ:GANX
|
US |
|
Fujian Expressway Development Co Ltd
SSE:600033
|
CN |
|
R
|
Recharge Resources Ltd
CNSX:RR
|
CA |
|
Hydrix Ltd
ASX:HYD
|
AU |
|
B
|
BCWorldPharm Co Ltd
KOSDAQ:200780
|
KR |
|
C
|
Chykingyoung Investment Development Holdings Inc
OTC:CHYI
|
CA |
|
Green Mining Innovation Inc
XTSX:GMI
|
CA |
|
Auden Techno Corp
TWSE:3138
|
TW |
Intrinsic Value
The intrinsic value of one
GANX
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 1.94 USD,
Gain Therapeutics Inc
is
hidden
.
GANX looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether GANX usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Gain Therapeutics Inc.
The intrinsic value of one
GANX
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 1.94 USD,
Gain Therapeutics Inc
is
hidden
.